Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.

Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK.

Science. 2005 Mar 4;307(5714):1434-40. Epub 2005 Jan 6.

2.

Susceptibility to HIV/AIDS: an individual characteristic we can measure?

Jülg B, Goebel FD.

Infection. 2005 Jun;33(3):160-2. Review.

PMID:
15940420
3.

HIV-1/AIDS susceptibility and copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-receptor CCR5.

Nakajima T, Kaur G, Mehra N, Kimura A.

Cytogenet Genome Res. 2008;123(1-4):156-60. doi: 10.1159/000184703. Epub 2009 Mar 11. Review.

PMID:
19287150
4.

CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.

Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, Anaya JM, Miura T, Hecht FM, Mamtani M, Pereyra F, Marconi V, Mangano A, Sen L, Bologna R, Clark RA, Anderson SA, Delmar J, O'Connell RJ, Lloyd A, Martin J, Ahuja SS, Agan BK, Walker BD, Deeks SG, Ahuja SK.

Nat Immunol. 2007 Dec;8(12):1324-36. Epub 2007 Oct 21.

PMID:
17952079
5.

CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection.

Shao W, Tang J, Song W, Wang C, Li Y, Wilson CM, Kaslow RA.

Genes Immun. 2007 Apr;8(3):224-31. Epub 2007 Mar 1.

PMID:
17330138
6.

CCL3L1 and HIV/AIDS susceptibility.

Bhattacharya T, Stanton J, Kim EY, Kunstman KJ, Phair JP, Jacobson LP, Wolinsky SM.

Nat Med. 2009 Oct;15(10):1112-5. doi: 10.1038/nm1009-1112. No abstract available.

PMID:
19812561
7.

CCL3L1 dose and HIV-1 susceptibility.

Mackay CR.

Trends Mol Med. 2005 May;11(5):203-6. Review.

PMID:
15882607
8.

CCL3L1 and HIV/AIDS susceptibility.

Urban TJ, Weintrob AC, Fellay J, Colombo S, Shianna KV, Gumbs C, Rotger M, Pelak K, Dang KK, Detels R, Martinson JJ, O'Brien SJ, Letvin NL, McMichael AJ, Haynes BF, Carrington M, Telenti A, Michael NL, Goldstein DB.

Nat Med. 2009 Oct;15(10):1110-2. doi: 10.1038/nm1009-1110. No abstract available.

9.

Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis.

McKinney C, Merriman ME, Chapman PT, Gow PJ, Harrison AA, Highton J, Jones PB, McLean L, O'Donnell JL, Pokorny V, Spellerberg M, Stamp LK, Willis J, Steer S, Merriman TR.

Ann Rheum Dis. 2008 Mar;67(3):409-13. Epub 2007 Jun 29.

PMID:
17604289
10.

HIV/AIDS. HIV: experiencing the pressures of modern life.

Nolan D, James I, Mallal S.

Science. 2005 Mar 4;307(5714):1422-4. No abstract available.

PMID:
15746416
11.

[Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].

Wasik TJ, Smoleń J, Kruszyński P, Bratosiewicz-Wasik J, Beniowski M.

Wiad Lek. 2005;58(9-10):500-7. Polish.

PMID:
16529059
12.

Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C.

Grünhage F, Nattermann J, Gressner OA, Wasmuth HE, Hellerbrand C, Sauerbruch T, Spengler U, Lammert F.

J Hepatol. 2010 Feb;52(2):153-9. doi: 10.1016/j.jhep.2009.11.001. Epub 2009 Nov 27.

PMID:
20044164
13.

Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.

Rathore A, Chatterjee A, Sivarama P, Yamamoto N, Singhal PK, Dhole TN.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1149-56. doi: 10.1089/aid.2008.0019.

PMID:
19886839
14.

Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication.

Pilotti E, Elviri L, Vicenzi E, Bertazzoni U, Re MC, Allibardi S, Poli G, Casoli C.

Blood. 2007 Mar 1;109(5):1850-6. Epub 2006 Oct 24.

15.

CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.

Kulkarni H, Agan BK, Marconi VC, O'Connell RJ, Camargo JF, He W, Delmar J, Phelps KR, Crawford G, Clark RA, Dolan MJ, Ahuja SK.

PLoS One. 2008 Sep 8;3(9):e3165. doi: 10.1371/journal.pone.0003165.

16.

The impact of CCL3L1 copy number in an HIV-1-infected white population.

Lee EY, Yue FY, Jones RB, Lo C, Sheth P, Hyrcza MD, Kovacs C, Benko E, Kaul R, Ostrowski M.

AIDS. 2010 Jun 19;24(10):1589-91. doi: 10.1097/QAD.0b013e3283398294.

PMID:
20442635
17.

Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands.

Arenzana-Seisdedos F, Parmentier M.

Semin Immunol. 2006 Dec;18(6):387-403. Epub 2006 Sep 15. Review.

PMID:
16978874
18.

CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus.

Mamtani M, Rovin B, Brey R, Camargo JF, Kulkarni H, Herrera M, Correa P, Holliday S, Anaya JM, Ahuja SK.

Ann Rheum Dis. 2008 Aug;67(8):1076-83. Epub 2007 Oct 30.

19.

HIV-1 pathogenesis: the complexities of the CCR5-CCL3L1 complex.

Moore JP, Klasse PJ.

Cell Host Microbe. 2007 Nov 15;2(5):281-3. Review.

20.

Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.

Verma R, Gupta RB, Singh K, Bhasin R, Anand Shukla A, Chauhan SS, Luthra K.

J Clin Virol. 2007 Mar;38(3):198-203. Epub 2007 Jan 19.

PMID:
17240189

Supplemental Content

Support Center